NCT00300521View on ClinicalTrials.gov

Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

November 30, 2005

Conditions
Hepatocellular CarcinomaLiver Transplantation
Interventions
GENETIC

ADV-TK (adenovirus-thymidine kinase enzyme) gene therapy

Trial Locations (1)

100020

Beijing Chao Yang Hospital, Beijing

All Listed Sponsors
collaborator

Tongji University

OTHER

collaborator

The No.180 Hospital of People's Liberation Army

UNKNOWN

lead

Beijing Chao Yang Hospital

OTHER

NCT00300521 - Liver Transplantation With ADV-TK Gene Therapy Improves Survival in Patients With Advanced Hepatocellular Carcinoma | Biotech Hunter | Biotech Hunter